Pasithea Therapeutics Corp (NASDAQ: KTTA) is -56.19% lower on its value in year-to-date trading and has touched a low of $0.92 and a high of $7.69 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The KTTA stock was last observed hovering at around $1.37 in the last trading session, with the day’s gains setting it 0.01%.
Currently trading at $1.38, the stock is 6.94% and 7.18% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.11 million and changing 0.73% at the moment leaves the stock -58.17% off its SMA200. KTTA registered -83.76% loss for a year compared to 6-month loss of -65.06%. The firm has a 50-day simple moving average (SMA 50) of $1.2876 and a 200-day simple moving average (SMA200) of $3.29929.
The stock witnessed a 20.00% gain in the last 1 month and extending the period to 3 months gives it a -43.67%, and is -13.75% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 21.67% over the week and 14.97% over the month.
Pasithea Therapeutics Corp (KTTA) has around 4 employees, a market worth around $3.74M and $0.00M in sales. Distance from 52-week low is 49.58% and -82.05% from its 52-week high. The company has generated returns on investments over the last 12 months (-94.06%).
8.0 institutions hold shares in Pasithea Therapeutics Corp (KTTA), with institutional investors hold 5.11% of the company’s shares. The shares outstanding are 2.71M, and float is at 2.19M with Short Float at 0.66%. Institutions hold 4.65% of the Float.
